Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Free Research Reports on AMD, CYCC, GNK and KSS Issued by the Bedford Report

AMD, CYCC, KSS
Free Research Reports on AMD, CYCC, GNK and KSS Issued by the Bedford Report
http://media.marketwire.com/attachments/201211/53317_equitynewscircuit-logo-final.jpghttp://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1018526&ProfileId=051205&sourceType=1

NEW YORK, NY -- (Marketwired) -- 05/17/13 -- The Bedford Report has released new equity reports today. As a leading provider of free in depth reports and timely market updates, Bedford is an essential resource for hundreds of thousands of investors across the country.

Advanced Micro Devices, Inc. (NYSE: AMD) dropped 12.56 percent on volume of over 80.0 million shares traded Thursday to close at $3.83 a share. Goldman Sachs analyst James Covello has recently downgraded the company's rating to "sell" from "neutral". Shares of the company have rallied more than 54 percent in the past month on its future gaming potential.

Find out more about Advanced Micro Devices including full access to the free equity report at: www.BedfordReport.com/AMD

Cyclacel Pharmaceuticals Inc. (NASDAQ: CYCC) shares declined 13.54 percent on volume of 2.58 million shares traded to close at $3.00 a share. The company announced the pricing of an underwritten offering of 6,666,667 shares of its common stock at $3.00 per share.

Find out more about Cyclacel Pharmaceuticals including full access to the free equity report at: www.BedfordReport.com/CYCC

Genco Shipping & Trading Limited (NYSE: GNK) shares spiked 16.3 percent on volume of nearly 3.5 million shares traded Thursday to close at $1.57 a share. Shipping stocks were buoyed by a surprising first quarter profit from Eagle Bulk Shipping Inc. Eagle also reported revenues for the quarter grew 37 percent to $72.2 million.

Find out more about Genco Shipping & Trading including full access to the free equity report at: www.BedfordReport.com/GNK

Kohl's Corporation (NYSE: KSS) shares spiked 4.73 percent on more than four times the average daily volume Thursday to close at $52.03 a share. The company reported a net income of $147 million, or $0.66 a share, for the first quarter of 2013, which topped Zacks Consensus Estimate of $0.58 per share.

Find out more about Kohl's including full access to the free equity report at: www.BedfordReport.com/KSS

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. A third party, Providence Media Strategies LLC has paid Equity News Circuit five hundred dollars for the publication of this news release. Neither Equity News Circuit, nor the hiring party, has a financial relationship with any company whose stock is mentioned in this release. Neither Equity News Circuit nor the hiring party are a registered investment advisor, and nothing in this report is intended as a solicitation to buy or sell any security.

Contact Information:

Equity News Circuit
Email Contact